Deniz Kent, PhD, is the Co-Founder and CEO of Prolific Machines, a biotechnology company revolutionizing cellular manufacturing with light. Deniz’s scientific breakthroughs paved the way for Prolific's cutting-edge technology, including co-discovering a human liver stem cell population and conducting the world’s first high-throughput small molecule screen using IPS-derived hepatocytes. Deniz earned his PhD from King’s College London and previously worked in cancer immunotherapy and regenerative medicine, bringing deep scientific expertise to his role as CEO.